The use of toxicology in the regulatory process

Principles and Methods of Toxicology: Fifth Edition

Volumn , Issue , 2007, Pages 45-102

  Beck, Barbara D ^a   Calabrese, Edward J ^b   Slayton, Tracey M ^a   Rudel, Ruthann ^c  

^a GRADIENT   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c SILENT SPRING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900015010     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (298)

1. I Iütt, P. B. (1985): Use of quantitative risk assessment in regulatory decisionmaking under federal health and safety statutes. In: Risk Quantitation and Regulatory Policy, edited by D. G. Hoel, R. A., Merrill, and F. P. Perera, Banbury Report 19. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p. 15.
2. Pott, P. (1779): Cancer scroti. In The Chirurgical Works, A New Edition in Three Volumes, Volume I. London.
3. NYSDEC (1986): New York State Air Guide 1: Guidelines for the Control of Toxic Ambient Air Contaminants. Division of Air Resources, New York State Department of Environmental Conservation, Albany, NY.
4. EPA (2004). Chemical Information Collection and Data Development (Testing), Master Testing List: Introduction. U.S. Environmental Protection Agency, Washington, D.C. (http:/www.epa.gov/opptintr/chemtest/mtlintro.htm).
5. Carson, R. L. (1962): Silent Spring. Houghton Mifflin, Boston, MA.
6. CDC (2005): Third National Report on Human Exposure to Environmental Chemicals. NCEH Pub. No. 05-0570, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
7. Public Law 85-929 (1958): Food Additives Amendment of 1958.
8. U. S. Food and Drug Administration (1986): Listing of D&C orange no. 17 for use in externally applied drugs and cosmetics, final rule. Fed. Reg., 51:28331.
9. Scheuplein, R. J. (1987): Risk assessment and food safety: a scientist and regulator's view. Food Drug Cosm. Law J., 42:237.
10. National Research Council (1987): Regulating Pesticides in Food: The Delaney Paradox, National Academy Press, Washington, D.C.
11. Abelson, P. H. (1993): Pesticides and food. Science, 259:1235.
12. U.S. Food and Drug Administration (1988): Color additives: denial of petition for listing of D&C red no. 19 for use in externally applied drugs and cosmetics. Fed. Reg., 53:26831.
13. OSHA (1970): Occupational Safety and Health Act of 1970, 29 U.S.C. 655.
14. Rodricks, J. V. and Taylor, M. R. (1989): Comparison of risk management in U.S. regulatory agencies. J. Haz. Mater., 21:239.
15. Industrial Union Department (1980): AFL-CIO v. American Petroleum Institute, 448 U.S. 60165 L. Ed. 2d 1010, 100 S. Ct. 2844.
16. EPA (1999): Summary of FQPA amendments to FIFRA and FFDCA, U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/oppfead1/fqpa/fqpa-iss. htm).
17. OMB (1990): Current regulatory issues in risk assessment and management. In: Regulatory Program of the United States Government. Executive Office of the President, Office of Management and Budget, Washington, D.C.
18. Thorton, J. (1991): Written testimony of J. Thornton [Greenpeace U.S.A.] for the U.S. House of Representatives Committee on Science, Space, and Technology, Subcommittee on Environment, Hearing on Risk Assessment: Strengths and Limitations of Utilization for Policy Decisions, May 21.
19. Finkel, A. M. (1991): Testimony before the U.S. House of Representatives Committee on Science, Space, and Technology, Subcommittee on Environment, Hearing on Risk Assessment: Strengths and Limitations of Utilization for Policy Decisions, May 21.
20. EPA (1999): Reference Dose (RfD): Description and Use in Health Risk Assessments, (Background Document 1A). Integrated Risk Information System, U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov.ngispgm3/iris/rfd.htm).
21. ACGIH (1992): Threshold Limit Values for Chemical Substances and Physical Agents. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
22. DHHS (1985): Risk Assessment and Risk Management of Toxic Substances. Report to the Secretary of DHHS from the Executive Committee of the DHHS Committee to Coordinate Environmental and Related Programs. U.S. Department of Health and Human Services, Washington, D.C.
23. Commission on the European Communities (2000): Communication from the Commission on the Precautionary Principle. Brussels, Belgium (http://europa.eu.int/comm/dgs/health_consumer/library/pub/pub07_en.pdf).
24. European Union (2000): EU's Communication on Precautionary Principle. European Union, Brussels, Belgium (http://www.gdrc.org/u-gov/precaution-4.html).
25. Europa (2003): The New EU Chemicals Legislation: REACH. European Commission, Brussels, Belgium (http://europa.eu.int/comm/enterprise/reach/index_en.htm).
26. National Research Council (1983): Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, D.C.
27. National Research Council (1994): Science and Judgment in Risk Assessment, National Academy Press, Washington, D.C.
28. The Presidential/Congressional Commission on Risk Assessment and Risk Management (1997): Risk Assessment and Risk Management in Regulatory Decision-Making, Vol. 2, Final Report.
29. U.S. Department of Health and Human Services (1986): NIOSH recommendations for occupational safety and health standards. Morbid. Mortal. Weekly Rep., 35:1S.
30. Nichols A. L. and Zeckhauser, R. J. (1986): The perils of prudence: how conservative risk assessments distort regulation, Regulation, 10:13.
31. Graham, J. D. and Wiener, J. B., Eds. (1995): Risk vs. Risk: Tradeoffs in Protecting Health and the Environment. Harvard University Press, Cambridge, MA.
32. Rosenthal, A., Graf, G. M., and Graham, J. D. (1992): Legislating acceptable cancer risk from exposure to toxic chemicals. Ecol. Law Q., 19:269.
33. Anderson, P. D. (1988): Scientific origins of incompatibility in risk assessment. Stat. Sci., 3:320.
34. Seeley, M. R. et al. (2001): Procedures for health risk assessment in Europe. Regul. Toxicol. Pharmacol., 34:153.
35. Travis, C. C. et al. (1987): Cancer risk management. Environ. Sci. Technol., 21:415.
36. Travis, C. C. and Hattemer-Fry, H. A. (1988): Determining an acceptable level of risk. Environ. Sci. Technol., 22:873.
37. Miller, F. J., Illing, J. W., and Gardner, D. E. (1978): Effect of urban ozone levels on laboratory-induced respiratory infections, Toxicol. Lett., 2:163.
38. Green, G. M. (1984): Similarities of host defense mechanisms against pulmonary disease in animals and man. J. Toxicol. Environ. Health, 13:471.
39. EPA (1989): Review of the National Ambient Air Quality Standardfor Ozone: Assessment of Scientific and Technical Information. Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, Research Triangle Park, N.C.
40. IARC (1982): Evaluation of Carcinogenic Risk of Chemicals to Humans, IARC Monographs, Suppl. 4. International Agency for Research on Cancer, Lyons, France.
41. EPA (2005): Guidelines for Carcinogen Risk Assessment, EPA/630/P-03-001F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
42. Occupational Safety and Health Administration (1980): Identification, classification, and regulation of potential occupational carcinogens, Fed. Reg., 45:5002.
43. Wallace, L. A. et al. (1983): Personal exposure of volatile organics and other compounds indoors and outdoors: the TEAM study. In: Proc. of the 76th Annual Meeting of the Air Pollution Control Association. Air Pollution Control Association, Pittsburgh, PA, 1983.
44. Tosteson, T., Spengler, J. D., and Weber, R. A. (1982): Aluminum, iron, and lead content of respirable particulate samples from a personal monitoring system. Environ. Int., 2:265.
45. McKone, T. E. and Bogen, K. T. (1991): Predicting the uncertainties in risk assessment, Environ. Sci. Technol., 25:1674.
46. Van Landingham, C. B., Lawrence, G. A., and Shipp, A. M. (2004): Estimates of lifetime-absorbed daily doses from the use of personal-care products containing polyacryla-mide: a Monte Carlo analysis. Risk Anal., 24:603.
47. Thompson, K. M., Burmaster, D. E., and Crouch, E. A. C. (1992): Monte-Carlo techniques for quantitative uncertainty analysis in public health risk assessments. Risk Anal., 12:53.
48. EPA (1997): Guiding Principles for Monte Carlo Analysis, EPA/630/R-97/001. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
49. Cullen, A. C. and Frey, H. C., Eds. (1999): Probabilistic Techniques in Exposure Assessment: A Handbook for Dealing with Variability and Uncertainty in Models and Inputs. Plenum Press, New York.
50. National Research Council (NRC), Understanding Risk: Informing Decisions in a Democratic Society, edited by P. C. Stern and H. V. Fineberg. National Academy Press, Washington, DC, 1996.
51. EPA (1995): Guidance for Risk Characterization. Science Policy Council, U.S. Environmental Protection Agency, Washington, D.C.
52. Infante, P. F. et al. (1977): Leukemia in benzene workers. Lancet, ii:76.
53. Maltoni, C., Conti, B., and Cotti, G. (1983): Benzene: a multi-potential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Am. J. Ind. Med., 4:589.
54. Lipfert, F. W. (1980): Sulfur oxides, particulates and human mortality: synopsis of statistical correlations. J. Air Pollut. Control Assoc., 30:366.
55. Quakenboss, J. J. et al. (1982): Personal monitoring for nitrogen dioxide exposure: methodological considerations for a community study. Environ. Int., 8:249.
56. Sax, S. N. et al. (2004): Differences in source emission rates of volatile organic compounds in inner-city residences of New York City and Los Angeles. J. Expo. Anal. Environ. Epidemiol., 14:S95.
57. Thurston, G. D. et al., Reexamination of London, England, mortality in relation to exposure to acidic aerosols during 1963-1972 winters. Environ. Health Perspect., 79:73.
58. Valberg, P. A. (2004): Is PM more toxic than the sum of its parts? Risk-assessment toxicity factors vs. PM-mortality "effect functions." Inhal. Toxicol, 16:19.
59. CDC (1991): Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control. U.S. Public Health Services, Washington, D.C.
60. Calabrese, E. J. (1978): Pollutants and High Risk Groups. John Wiley & Sons, New York.
61. Enterline, P. E. (1983): Epidemiologic basis for the asbestos standard. Environ. Health Perspect., 52:93.
62. Bethel, R. A. et al. (1983): Sulfur dioxide-induced bron-choconstriction in freely breathing exercising, asthmatic subjects, Am. Rev. Respir. Dis., 128:987.
63. Roger, L. J. et al. (1985): Bronchoconstriction in asthmatics exposed to sulfur dioxide during repeated exercise. J. Appl. Physiol., 59:784.
64. EPA (1986): Review of the National Ambient Air Quality Standards for Sulfur Oxides: Updated Assessment of Scientific and Technical Information, EPA-450/5-86-013, Addendum to the 1982 OAQPS Staff Paper. Office of Air Quality, Planning, and Standards, U.S. Environmental Protection Agency, Washington, D.C.
65. National Academy of Sciences (2004): Intentional Human Dosing Studies for EPA Regulatory Purposes: Scientific and Ethical Issues. Committee on the Use of Third-Party Toxicity Research with Human Research Participants; Science, Technology, and Law Program; Policy and Global Affairs Division, National Research Council of the National Academies, Washington, D.C.
66. Wiles, R. [Environmental Working Group] (2005): Letter to Taylor, M. R. [National Academy of Sciences] re: using humans in laboratory tests, February 23, 2004.
67. Greer, M. A. et al. (2002): Health effects assessment for environmental perchlorate contamination: the dose-response for inhibition of thyroidal radioiodine uptake in humans. Environ. Health Perspect., 110:927.
68. National Academy of Sciences (2004): Committee to Assess the Health Implications of Perchlorate Ingestion. National Academy of Sciences, Washington, D.C. (http://www4.nas.edu/webcr.nsf/ProjectScopeDisplay/BEST-K-03-05-A?OpenDocument).
69. Chang, L.-Y. et al. (1992): Epitheliel injury and interstitial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone. Toxicol. Appl. Pharmacol., 115:241.
70. Germolec, D. R. et al. (1989): Toxicology studies of a chemical mixture of 25 groundwater contaminants. II. Immunosuppression in B5C3F1 mice. Fundam. Appl. Toxicol., 13:377.
71. Elsayed, N. M. and Mustafa, M. G. (1982): Dietary antioxidants and the biochemical response to oxidant inhalation. I. Influence of dietary vitamin E on the biochemical effects of nitrogen dioxide exposure in rat lung. Toxicol. Appl. Pharmacol., 66:319.
72. Kouri, R. E. and Nebert, D. W. (1977): Genetic regulation of susceptibility to polycyclic hydrocarbon induced tumors in the mouse. In: Origins of Human Cancer, edited by H. H. Hiatt, J. D. Watson, and J. A. Winstyen. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 811.
73. Nebert, D. W. (1989): The Ah locus: genetic differences in toxicity, cancer, mutation. Crit. Rev. Toxicol., 20:153.
74. Waters, M. D. and Fostel, J. M. (2004): Toxicogenomics and systems toxicology: aims and prospects. Nature Rev. Gen., 5:936.
75. International Programme on Chemical Safety Workshop (2003): Toxicogenomics and the Risk Assessment of Chemicals for the Protection of Human Health, Summary. World Health Organization, International Labour Organization, United Nations Environment Programme, held at the Federal Institute for Risk Assessment, Berlin, Germany, November 17-19.
76. Cohen, S. M. et al. (2003): The human relevance of information on carcinogenic modes of action: overview. Crit. Rev. Toxicol., 33:581.
77. Agency for Toxic Substances and Disease Registry (1997): Toxicological Profile for Trichloroethylene: Update. Sciences International, Inc., and U.S. Public Health Services, U.S. Environmental Protection Agency, Washington, D.C.
78. Heinrich, U. et al. (1986): Chronic effects on the respiratory tract of hamsters, mice and rats after long-term inhalation of high concentrations of filtered and unfiltered diesel engine emissions. J. Appl. Toxicol., 6:383.
79. ILSI Risk Science Institute (2000): The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report, ILSI Risk Science Workshop Participants. Inhal. Toxicol. 12:1.
80. Enslein, K. (1987): Computer-assisted prediction of toxicity. In Toxic Substances and Human Risk: Principals of Data Interpretation. edited by R. G. Tardiff and J. V. Rodricks. Plenum Press, New York, p. 317.
81. Beck, B. D. et al. (1991): Utilization of quantitative structure activity relationships (QSARs) in risk assessment. Reg. Toxicol. Pharmacol., 14:273.
82. Hart, R. W. and Turturro, A. (1988): Introduction. In: Banbury Report 31: Carcinogen Risk Assessment-New Directions in the Qualitative and Quantitative Aspects, edited by R. W. Hart and F. D. Hoerger. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
83. Linkov, I., Wilson, R., and Gray, G. M. (1998): Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects. Toxicol. Sci., 43:1.
84. Pitot, H. C. and Dragan, Y. P. (1991): Facts and theories concerning the mechanisms of carcinogenesis. FASEB J., 5:2280.
85. Trosko, J. E. and Chang, C. C. (1988): Nongenotoxic mechanisms in carcinogenesis: role of inhibited intercellular communication. In: Banbury Report 31: Carcinogen Risk Assessment-New Directions in the Qualitative and Quantitative Aspects, edited by R. W. Hart and F. D. Hoerger. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
86. Cohen, S. M. et al. (2005): Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol., 36(2):99.
87. Cohen, S. M. et al. (2004): Evaluating the human relevance of chemically induced animal tumors. Toxicol. Sci., 78:181.
88. Roe, F. J. (1989): Non-genotoxic carcinogenesis: implications for testing and extrapolation to man. Mutagenesis, 4:407.
89. Moolgavkar, S. H. (1986): Carcinogenesis modeling: from molecular biology to epidemiology. Ann. Rev. Public Health, 7:151.
90. Graham, J. D. (1992): Recommendations for Improving Cancer Risk Assessment. Center for Risk Analysis, Harvard School of Public Health, Boston, MA.
91. EPA (2005): Guidelines for Carcinogen Risk Assessment (Final), EPA/630/P-03/001B. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C. (http:// cfpub.epa.gov/ncea/cfm/recordis-play.cfm?deid=116283).
92. Tennant, R. W., French, J. E., and Spalding, J. W. (1995): Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect., 103:942.
93. Sontag, J. M., Page, N. P., and Sanotti, U. (1976): Guidelines for Carcinogen Bioassays in Small Rodents, DHHS Publ. (NIH) 76-801. National Cancer Institute, Bethesda, MD.
94. Haseman, J. K. (1985): Issues in carcinogenicity testing: dose selection. Fund. Appl. Toxicol., 5:66.
95. Munro, I. C. (1977): Considerations in chronic toxicity testing: the chemical, the dose, the design. J. Environ. Pathol. Toxicol., 1:183.
96. Melnick, R.L. et al. (1984): Toxicity and carcinogenicity of melamine in F344 rats and B5C3F1 mice. Toxicol. Appl. Pharmacol., 72:292.
97. Clayson, D. B. and Clegg, D. J. (1991): Classification of carcinogens: polemics, pedantics, or progress? Reg. Tox. Pharm., 14:147.
98. Ames, B. N. and Gold, L. S. (1990): Too many rodent carcinogens: mitogenesis increases mutagenesis. Science, 249:970.
99. Ames, B. N., Swirsky-Gold, L., and Shigenaga, M. K. (1996): Cancer prevention, rodent high-dose cancer tests, and risk assessment. Risk Anal., 16:613.
100. Rieth, J. P. and Starr, T. B. (1989): Chronic bioassays: relevance to quantitative risk assessment of carcinogens. Reg. Tox. Pharm., 10:160.
101. Goodman, G. and Wilson, R. (1992): Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal., 12:525.
102. Gaylor, D. W. (2005): Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regul. Toxicol. Pharmacol., 41:128.
103. Foran, J. A. and the ILSI Risk Science Working Group on Dose Selection (1997): Principles for the selection of doses in chronic rodent bioassays. Env. Health Perspect., 105.
104. IARC (1980): Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal, IARC Monographs, Supplement 2, International Agency for Research on Cancer, Lyons, France.
105. U.S. Environmental Protection Agency (1986): Guidelines for carcinogen risk assessment, Fed. Reg., 51:33992.
106. Hart, R. W. and Fishbein, L. (1985): Interspecies extrapolation of drug and genetic toxicity data. In: Toxicological Risk Assessment, Vol. I, edited by D. B. Clayson, D. Krewski, and I. Munro. CRC Press, Boca Raton, FL, p. 3.
107. IARC (1997): Polychlorinated Dibenzo-Para-Dioxins and Polychlorinated Dibenzofurans, Vol. 69, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland.
108. EPA (2003): Exposure and Human Health Risk Assessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. Part II. Health Assessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds, NAS Review Draft (Dioxin Reassessment). National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, D.C.
109. EPA (2003): Exposure and Human Health Risk Assessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. Part III. Integrated Summary and Risk Characterization for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds, NAS Review Draft (Dioxin Reassessment). National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, D.C.
110. Cole, P. (2003): Dioxin and cancer: a critical review. Regul. Toxicol. Pharmacol., 38:378.
111. Strauss, H. S. (1993): Sex biases in the risk assessment of toxic chemicals, presented at the Annual Meeting of the American Association for the Advancement of Science, Boston, MA, February 12.
112. IARC (1987): Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Suppl. 7, IARC Monographs. International Agency for Research on Cancer, Lyons, France.
113. Tomatis, L. et al. (1989): Human carcinogens so far identified. Jpn. J. Cancer Res., 80:795.
114. Waring, M. J., DNA modification and cancer. Annu. Rev. Biochem., 50:159.
115. Popper, H., Maltoni, C., and Selikoff, I. J. (1980): Vinyl chloride-induced hepatic lesions in man and rodents: a comparison, Liver, 1:7.
116. Butterworth, B. E. (1990): Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat. Res., 239:117.
117. Zeise, L., Wilson, R., and Crouch, E. A. C. (1987): Dose-response relationships for carcinogens: a review, Environ. Health Perspect., 73, 259, 1987.
118. Cohen, S. M. and Ellwein, L. B., Biological theory of carcinogenesis: implications for risk assessment. In: Low-Dose Extrapolation of Cancer Risks, edited by S. Olin et al. ILSI Press, Washington, D.C., p. 145.
119. Conolly, R. B. et al., Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci., 82, 279, 2004.
120. Golden, R. J. et al. (1997): Chloroform in mode of action: implications for cancer risk assessment. Regul. Toxicol. Pharmacol., 26:142.
121. U. S. Interagency Staff Group of Carcinogens (1986): Chemical carcinogens: a review of the science and its associated principals. Environ. Health Perspect., 67:201.
122. Ziskind, M., Jones, R. N., and Weil, H. (1976): Silicosis. Am. Rev. Respir. Dis., 113:643.
123. National Research Council (1986): Drinking Water and Health, Vol. 6. National Academy Press, Washington, D.C.
124. Dourson, M. L. and Stara, J. F. (1986): Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol., 3:224.
125. EPA (1990): General Quantitative Risk Assessment Guidelines for Noncancer Health Effects, ECAO-CIN-538. Technical Panel for the Development of Risk Assessment Guidelines for Noncancer Health Effects, U.S. Environmental Protection Agency, Washington, D.C.
126. EPA (1999): IRIS Substance File for Chromium (VI), CASRN 18540-29. U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/ngispgm3/iris/subst/0144.htm).
127. EPA (1999): IRIS Substance File for Fluorine (Soluble Fluoride), CASRN 7782-41-4. U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/ngispgm3/iris/subst/0053.htm).
128. Beck, B. D. et al. (1993): Improvements in quantitative noncancer risk assessment. Fund. Appl. Toxicol., 20:1.
129. Crump, K. S. (1984): A new method for determining allowable daily intake. Fund. Appl. Toxicol., 4:854.
130. Dourson, M. L. (1986): New approaches in the derivation of acceptable daily intake (ADI), Comments Toxicol., 1:35.
131. Calabrese, E. J., Beck, B. D., and Chappell, W. R. (1992): Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area? Reg. Toxicol. Pharmacol., 15:172.
132. Conolly, R. B. and Butterworth, B. E. (1995): Biologically based dose response model for hepatic toxicity: a mechanistically based replacement for traditional estimates of noncancer risk, Toxicol. Lett., 82/83:901.
133. Jarabek, A. M. et al. (1990: The U.S. Environmental Protection Agency's inhalation RfD methodology: risk assessment for air toxics. Toxicol. Ind. Health, 6:279.
134. EPA (1990): Interim Methods for Development of Inhalation Reference Concentrations, Review Draft, EPA/600/8-90/066A. Environmental Criteria and Assessment Office, U.S. Environmental Protection Agency, Washington, D.C.
135. Overton, J. H. and Jarabek, A. M. (1989): Estimating equivalent human concentrations of no observed adviser effect levels: a comparison of several methods. Exp. Pathol., 37:89.
136. WHO (1994): International Programme on Chemical Safety: Assessing Human Health Risks of Chemicals-Derivation of Guidance Values for Health-Based Exposure Limits, Environmental Health Criteria 170. International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland.
137. WHO (1999): International Programme on Chemical Safety: Assessing Human Health Risks of Chemicals-Principles for the Assessment of Risk to Human Health from Exposure to Chemicals, Environmental Health Criteria 210. World Health Organization, Geneva, Switzerland.
138. EPA (2004): Boron and Compounds, CASRN 7440-42-8. Integrated Risk Information System, U.S. Environmental Protection Agency, Washington, D.C. (http://cfpub.epa.gov/iris/quickview.cfm?substance:nmbr=0410).
139. Faustman, E. M. (1996): Review of Noncancer Risk Assessment: Application of Benchmark Dose Methods, prepared for the Presidential/Congressional Commission on Risk Assessment and Risk Management, Washington, D.C.
140. EPA (1995): The Use of the Benchmark Dose Approach in Health Risk Assessment, EPA/630/R-94/007. Risk Assessment Forum, Office of Research and Development, U.S. Environmental Protection Agency, Washington, D.C.
141. Slob, W. and Pieters, M. N. (1997): A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework, Report No. 620110-005. National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
142. Baird, S. J. S. et al. (1996): Noncancer risk assessment: a probabilistic alternative to current practice. Hum. Ecol. Risk Assess., 2:79.
143. EPA (2000): Benchmark Dose Technical Guidance Document, Preliminary Draft, EPA/630/R-00/001. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
144. Crump, K. S., Clewell, H. J., and Andersen, M. E. (1997): Cancer and non-cancer risk assessment should be harmonized. Hum. Ecol. Risk Assess., 3:495.
145. EPA (1999): Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, Washington, D.C.
146. EPA (1999): IRIS Substance File for Naphthalene, CASRN 91-20-3. U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/ngispgm3/iris/subst/0436.htm).
147. EPA (1992): Review of the National Ambient Air Quality Standards for Carbon Monoxide: 1992 Reassessment of Scientific and Technical Information, OAQPS staff paper. U.S. Environmental Protection Agency, Washington, D.C.
148. U.S. Environmental Protection Agency (1991): Guidelines for developmental toxicity, Fed. Reg., 56:63798.
149. Khera, K. S., Grice, H. C., and Clegg, D. J. (1989): Current Issues in Toxicology: Interpretation and Extrapolation of Reproductive Data To Establish Human Safety Standards. Springer-Verlag, New York.
150. U.S. PHS (1989): Toxicological Profile for Selected PCBs (Arochlor-1260, -1254, -1248, -1242, -1232, -1221, and -1016), Report No. ATSDR/TP-8821. Agency for Toxic Substances and Disease Registry, U.S. Public Health Service, Washington, D.C.
151. Chernoff, N. and Kavlock, R. J. (1982): An in vivo teratology screen utilizing pregnant mice. J. Toxicol. Environ. Health, 10:541.
152. Manson, J. M. and Wise, L. D. (1991): Teratogens. In: Casarett and Doull's Toxicology, edited by M. O. Amdur, J. Doull, and C. D. Klaassen. Pergamon Press, New York, p. 226.
153. IEHR (1992): An Evaluative Process for Determining Human Reproductive and Developmental Toxicity of Agents, Draft Version. Institute for Evaluating Health Risks, Washington, D.C.
154. Kavlock, R. J., Schmid, J. E., and Setzer, R. W. (1996): A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity. Risk Anal., 16:399.
155. American Cancer Society (2005): Cancer Facts and Figures 2005. American Cancer Society, Washington, D.C.
156. EPA (1988): Special Report on Ingested Inorganic Arsenic: Skin Cancer; Nutritional Essentiality, EPA-625/3-87-013F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
157. American Thoracic Society (1985): Guidelines as to what constitutes an adverse respiratory health effect with special reference to epidemiologic studies of air pollution. Am. Rev. Respir. Dis., 131:666.
158. American Thoracic Society (2000): What constitutes an adverse respiratory health effect for air pollution? Am. J. Respir. Crit. Care, 161:665.
159. deRosa, C. T., Stara, J. F., and Durkin, P. R. (1985): Ranking chemicals based on chronic toxicity data. Toxicol. Ind. Health, 1:177.
160. Andersen, M. E. et al. (1987): Physiologically based phar-macokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol., 87:185.
161. Calabrese, E. J. (1987): Animal extrapolation: a look inside the toxicologist's black box. Environ. Sci. Technol., 21:618.
162. Clewell, H. J. (1995): The use of physiologically based pharmacokinetic modeling in risk assessment: a case study with methylene chloride. In: Low-Dose Extrapolation of Cancer Risks, edited by S. Olin et al. ILSI Press, Washington, D.C., p. 199.
163. EPA (1999): IRIS Substance File for Dichloromethane, CASRN 75-09-2. U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/ngispgm3/iris/subst/0070.htm).
164. Hattis, D. et al. (1990): Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism creates for models derived by different authors. Risk Anal., 10:449.
165. Beck, B. D. (1997): The use of information on susceptibility in risk assessment: state of the science and potential for improvement. Environ. Toxicol. Pharmacol., 4:229.
166. Neumann D. A. and Kimmel, C. A., Eds. (1998): Human Variability in Response to Chemical Exposure. ILSI Press, Washington, D.C.
167. Cooper, W. C. (1973): Indicators of susceptibility to industrial chemicals. J. Occup. Med., 15, 355, 1973.
168. Carnow, B. W. (1976): Panel discussion on TLVs: lead. In: Health Effects of Occupational Lead and Arsenic Exposure: A Symposium, edited by B. Carnow. U.S. Public Health Service, National Institute for Occupational Safety and Health, Washington, D.C., p. 197.
169. Grassman, J. A., Kimmel, C. A., and Neumann, D. A. (1998): Accounting for variability in responsiveness in human health risk assessment. In: Human Variability in Response to Chemical Exposure, edited by D. A. Neumann and C. A. Kimmel. ILSI Press, Washington, D.C., p. 1.
170. Bromberg, P. A. (1998): Risk assessment of the effects of ozone exposure on respiratory health: dealing with variability in human responsiveness to controlled exposures. In: Human Variability in Response to Chemical Exposure, edited by D. A. Neumann and C. A. Kimmel. ILSI Press, Washington, D.C., p. 139.
171. Frame, L. T. et al. (1998): Host-environment interactions that affect variability in human cancer susceptibility. In: Human Variability in Response to Chemical Exposure, edited by D. A. Neumann and C. A. Kimmel. ILSI Press, Washington, D.C., p. 165.
172. Colditz, G. A., Stampfer, M. J., and Green, L. C. (1988): Diet. In: Variations in Susceptibility to Inhaled Pollutants, edited by B. D. Brain, A. J. Waven, and R. A. Shaiker. The Johns Hopkins University Press, Baltimore, MD, p. 314.
173. EPA (1996): A National Agenda To Protect Children's Health from Environmental Threats. U.S. Environmental Protection Agency, Washington, D.C. (http://occ-env-med.mc.duke.edu/oem/content/epa.htm).
174. U.S. Environmental Protection Agency (1998): Framework for addressing key scientific issues presented by the Food Quality Protection Act (FQPA) as developed by the Tolerance Reassessment Advisory Committee (TRAC). Fed. Reg., 63:58038.
175. Roberts, R. J. (1992): Overview of similarities and differences between children and adults: implications for risk assessment. In: Similarities and Differences Between Children and Adults: Implications for Risk Assessment, edited by P. S. Guzelian, C. J. Henry, and S. S. Olin. ILSI Press, Washington, D.C., p. 11.
176. Plunkett, L. M., Turnbull, D., and Rodricks, J. V. (1992): Differences between adults and children affecting exposure assessment. In: Similarities and Differences Between Children and Adults: Implications for Risk Assessment, edited by P. S. Guzelian, C. J. Henry, and S. S. Olin. ILSI Press, Washington, D.C., p. 79.
177. Kauffman, R. E. (1992): Acute acetaminophen overdose: an example of reduced toxicity related to developmental differences in drug metabolism. In: Similarities and Differences Between Children and Adults: Implications for Risk Assessment, edited by P. S. Guzelian, C. J. Henry, and S. S. Olin. ILSI Press, Washington, D.C., p. 97.
178. Guzelian, P. S. and Henry, C. J. (1992): Conference summary; similarities and differences between children and adults: implications for risk assessment (November 5-7, 1990, Hunt Valley, MD). In: Similarities and Differences Between Children and Adults: Implications for Risk Assessment, edited by P. S. Guzelian, C. J. Henry, and S. S. Olin. ILSI Press, Washington, D.C., p. 1.
179. Implementation Working Group (1998): A Science-Based, Workable Framework for Implementing the Food Quality Protection Act, Implementation Working Group's "Road Map" Report, prepared by Jellinek, Schwartz & Connolly, Inc.; McDermott, Will & Emery; and Morgan, Lewis & Bockius.
180. EPA (1998): Health Effects Division on FQPA Safety Factor for Infants and Children, presentation for FIFRE Scientific Advisory Panel by Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, D.C. (http://www.epa.gov/pesticides/SAP/march/10x.htm).
181. Tamplin, A. R. and Gofman, J. W. (1970: Population Control through Nuclear Pollution. Nelson-Hill, Chicago, IL.
182. Riddiough, C. R., Musselmann, R., and Calabrese, E. J. (1977): Is EPA's radium-226 drinking water standard justified? Med. Hypotheses, 3:171.
183. EPA (1986): Air Quality Criteria for Lead, Vols. I-IV, EPA-600/8-83/028adf. U.S. Environmental Protection Agency, Washington, D.C.
184. U.S. HEW (1962): Public Health Drinking Water Standards. Public Health Service, U.S. Department of Health, Education, and Welfare, Rockville, MD.
185. Betke, J., Kleihaver, E., and Lipps, M. (1956): Vergleichende Untersucheg uber Sportanozydation von Nabelschnur and Erwachsenenhamoglobin. Ztschr. Kinderh., 77:549.
186. Ross, J. D. and Des Forges, J. F. (1959): Reduction of methemoglobin by erythrocytes from cord blood: further evidence of deficient enzyme activity in newborn period. Pediatrics, 23:218.
187. U.S. Environmental Protection Agency (1975): Interim primary drinking water standards. Fed. Reg., 40:11990.
188. Ginsberg, G. L. (2003): Assessing cancer risks from shortterm exposures in children. Risk Anal., 23:19.
189. Preston, R. J. (2004): Children as a sensitive subpopulation for the risk assessment process. Toxicol. Appl. Pharmacol., 199:132.
190. EPA (2005): Supplemental Guidance for Assessing Susceptibility from Early Life Stage Exposure to Carcinogens, EPA/630/R-03/003F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
191. Eaton, D. L. and Klaassen, C. D. (2003): Principles of toxicology. In: Casarett & Doull's Essentials of Toxicology, edited by C. D. Klaassen and J. B. Watkins. McGraw-Hill, New York, chap. 2.
192. Calabrese, E. J. (2005): Hormesis: implications for risk assessment. In: Inhalation Toxicology, 2nd ed., edited by H. Salem and S. Katz. Marcel Dekker, New York.
193. Calabrese, E. J., Hormesis: a key concept in toxicology. In: Biological Concepts and Techniques in Toxicology: An Integrated Approach, edited by J. E. Riviere. Marcel Dekker, New York.
194. Rand, G., Ed. (2006): Fundamentals of Aquatic Toxicology,. Taylor & Francis, Boca Raton, FL, 2006.
195. Calabrese, E. J. (2003): Hormesis and Its Role in Toxicology, paper presented at the Society of Toxicology of Canada, Plenary Session, Montreal, Canada, December 8.
196. Hively, W. (2002): Is radiation good for you? Discover, 23(12):74.
197. Bethell, T. (2002): Underdosed: could toxins and radiation be good for you? Am. Spect., July/Aug.:54.
198. Lambert, E. (2003): A pinch of poison. Forbes Life Online (www.forbes.com).
199. Stipp, D. (2003): A little poison can be good for you. Fortune, 147:54.
200. Begley, S. (2003): Scientists revisit idea that a little poison could be beneficial. The Wall Street J., p. CCXLII, Dec. 19.
201. Cook, G. (2003): A scientist finds benefit in small doses of toxins. The Boston Globe, p. A16, Dec. 12.
202. Bell, J. (2004): Can a low dose of poison be a good thing? Baltimore Sun, March 15.
203. Boyce, N. (2004): Is there a tonic in the toxin? U.S. News World Rep., Oct. 18:74.
204. Ahuja, A. (2003): Science: some toxins may be good for us. Times Online (Lond.), Oct. 1.
205. Renner, R. (2003): Hormesis: Nietzsche's toxicology. Sci. Am., 289(3):28.
206. Renner, R. (2004): Redrawing the dose-response curve. Env. Sci. Technol., 38(5):90A.
207. Butler, R. (2004): When toxic turns to treatment. Chem. Indust., 3:10.
208. Hadley, C. (2003): What doesn't kill you makes you stronger. EMBO J., 4:924.
209. Calabrese, E. J. (2004): Hormesis: a revolution in toxicology, risk assessment and medicine. EMBO J., 5:S37.
210. Calabrese, E. J. and Baldwin, L. A. (2003): Toxicology rethinks its central belief: hormesis demands a reappraisal of the way risks are assessed. Nature, 421:691.
211. Kaiser, J. (2003): Sipping from a poisoned chalice. Science, 302:376.
212. Calabrese, E. J. and Baldwin, L. A. (2003): The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol. Sci., 71:246.
213. Rodricks, J. V. (2003): Hormesis and toxicological risk assessment. Toxicol. Sci., 71:134.
214. Calabrese, E. J. and Blain, R. (2005): The occurrence of hormetic dose responses in the toxicological literature: the hormesis database: an overview. Toxicol. Appl. Pharmacol., 202:289.
215. Calabrese, E. J. (2005): Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose-response model in the toxicological sciences. Environ. Pollut., 138:379.
216. Calabrese, E. J. and Baldwin, L. A. (2001): Special issue: scientific foundations of hormesis. Crit. Rev. Toxicol., 31:351.
217. Calabrese, E. J. and Baldwin, L. A. (2003): Special issue: hormesis: environmental and biomedical perspectives. Crit. Rev. Toxicol., 33:213.
218. Calabrese, E. J. (2005): Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit. Rev. Toxicol., 35:89.
219. Luckey, T. D. (1980): Ionizing Radiation and Hormesis. CRC Press, Boca Raton, FL.
220. Luckey, T. D. (1991): Radiation Hormesis. CRC Press, Boca Raton, FL.
221. Southam, C. M. and Ehrlich, J. (1943): Effects of extracts of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathology, 33:517.
222. Schulz, H. (1887): Zur Lehre von der Arzneiwirdung. Vir-chows Archiv. fur Pathol. Anatomie und Physiol. Fur Klin. Med., 108:423.
223. Schulz, H. (1923/2003): Contemporary Medicine as Presented by Its Practitioners Themselves. Leipzig, pp. 217-250; reprinted in Nonlinear Biol. Toxicol. Med., 1(3):295 (NIH Library Translation NIH-98-134, trans. by T. Crump).
224. Calabrese, E. J. and Baldwin, L. A., Chemical hormesis: its historical foundations as a biological hypothesis, Hum. Exper. Toxicol., 19, 2, 2000.
225. Calabrese, E. J. and Baldwin, L. A. (2000): The margin-alization of hormesis. Hum. Exp. Toxicol., 19:32.
226. Calabrese, E. J. and Baldwin, L. A. (2000): Radiation hormesis: its historical foundations as a biological hypothesis. Hum. Exp. Toxicol., 19:41.
227. Calabrese, E. J. and Baldwin, L. A. (2000): Radiation hormesis: the demise of a legitimate hypothesis. Hum. Exp. Toxicol., 19:76.
228. Calabrese, E. J. and Baldwin, L. A. (2000): Tales of two similar hypothesis: the rise and fall of chemical and radiation hormesis. Hum. Exp. Toxicol., 19:85.
229. Calabrese, E. J. and Baldwin, L. (1997): The dose determines the stimulation (and poison): development of a chemical hormesis database. Int. J. Toxicol., 16:545.
230. Paoletti, P. et al. (1990): Characteristics and biological role of steroid hormone receptors in neuroepithelial tumors. J. Neurosurg., 73:736.
231. Calabrese, E. J., Baldwin, L. A., and Holland, C. D. (1999): Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Anal., 19:261.
232. Calabrese, E. J. and Baldwin, L. A. (2001): The frequency of U-shaped dose-responses in the toxicological literature. Tox. Sci., 62:330.
233. Calabrese, E. J. (1996): Expanding the RfD concept to incorporate and optimize beneficial effects while preventing toxic responses from non-essential toxicants. Ecotox. Environ. Safety, 34:94.
234. Calabrese, E. J. and Baldwin, L. (1998): Hormesis as a default parameter in RfD derivation. BELLE Newslett., 7:1.
235. Gaylor, D. (1998): Safety assessment with hormetic effects. Hum. Exper. Toxicol., 17:251.
236. Sielken, R. L., Jr., and Stevenson, D. E. (1998): Some implications for quantitative risk assessment if hormesis exists. Hum. Exp. Toxicol., 17:259.
237. Calabrese, E. J. and Cook, R. (2005): Hormesis: how it could affect the risk assessment process. BELLE Newslett., 12:22.
238. Sukata, T. et al. (2002): Detailed low-dose study of 1,1-bis (p-chlorophenyl)-2,2,2-trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int. J. Cancer, 99:112.
239. Society of Toxicology Panel (1981): Re-examination of the ED01 study: adjusting for time on study. Fund. Appl. Toxicol., 1:67.
240. Calabrese, E. J. and Baldwin, L. A. (2002): Hormesis and high risk groups. Reg. Tox. Pharmacol., 35:414.
241. National Research Council (1980): Principles of Toxicological Interactions Associated with Multiple Chemical Exposures. National Academy Press, Washington, D.C.
242. Monosson, E. (2005): Chemical mixtures: considering the evolution of toxicology and chemical assessment. Environ. Health Perspect., 113:383.
243. Wilkinson, C. F. (1971): Effects of synergists on the metabolism and toxicity of anticholinesterase. Bull. WHO, 40:171.
244. Frawley, J. P. et al. (1957): Marked potentiation in mammalian toxicity from simultaneous administration of two anti-cholinesterase compounds. J. Pharmacol. Exp. Ther., 121:96.
245. Finney, D. J. (1952): Probit Analysis. Cambridge University Press, London.
246. Pozzani, U. S., Weil, C. S., and Carpenter, C. P. (1959): The toxicological basis of TLVs. 5. The experimental inhalation of vapor mixtures by rats, with notes upon the relationship between single dose inhalation and single dose oral data, Am. Ind. Hyg. Assoc. J., 20:364.
247. Smyth, H. F., Jr. et al. (1969): An exploration of joint toxic action: 27 industrial chemicals in rats in all possible pairs. Toxicol. Appl. Pharmacol., 14:340.
248. Feron, V. J. et al. (1995): Toxicology of chemical mixtures: challenges for today and the future. Toxicology, 105:415.
249. EPA (1988): Technical Support Document on Risk Assessment of Chemical Mixtures, EPA/600/8-90/064. National Technical Information Service, U.S. Environmental Protection Agency, Washington, D.C.
250. Mileson, B. E. et al. (1998): Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol. Sci., 41:8.
251. Bellin, J. S. et al. (1989): Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-dioxins and Dibenzofurans (CDDs and CDFs): A 1989 Update, EPA-625/3-89-016. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, D.C.
252. Pohl, H. R., Hansen, H., and Chou, C. H. (1997): Public health guidance values for chemical mixtures: current practice and future directions. Reg. Toxicol. Pharmacol., 26:322.
253. Research Triangle Institute (1998): Toxicological Profile for Polychlorinated Biphenyls (PCBs), Updated Draft for Public Comment. National Technical Information Service, Agency for Toxic Substances and Disease Registry (ATSDR), U.S. Public Health Service, Washington, D.C.
254. Cogliano, V. J. (1996): PCBs: Cancer Dose-Response Assessment and Application to Environmental Mixtures, NTIS PB96-140603, EPA/600/P-96/001A. National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, D.C.
255. IARC (2002): IARC Monograph Summary for Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene, and Styrene, International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
256. IARC (2003): Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, Vol. 86. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/htdocs/announcements/vol86.htm).
257. IARC (2004): IARC Monograph Summary for Some Drinking-Water Disinfectants and Contaminants, Including Arsenic. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc. fr/monoeval/allmonos.html).
258. IARC (1999): IARC Monograph Summary for Beryllium and Beryllium Compounds (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
259. IARC (2004): IARC Monograph Summary for Betel-Quid and Areca-Nut Chewing and Some Areca-Nut-Derived Nitrosamines. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
260. IARC (1999): IARC Monograph Summary for Cadmium and Cadmium Compounds (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
261. IARC (1999): IARC Monograph Summary for Ciclosporin (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
262. IARC (1999): IARC Monograph Summary for Epstein-Barr Virus (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
263. IARC (1999) IARC Monograph Summary for Oestrogen Replacement Therapy (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
264. IARC (1999): IARC Monograph Summary for Ethylene Oxide (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
265. IARC (2000): IARC Monograph Summary for Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
266. IARC (2004): IARC Monograph Summary for Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxy-2-propanol. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
267. IARC (1999): IARC Monograph Summary for Infection with Helicobacter pylori (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
268. IARC (1999): IARC Monograph Summary for Hepatitis B Virus (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
269. IARC (1999): IARC Monograph Summary for Hepatitis C Virus (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
270. IARC (2004): IARC Monograph Summary for Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene, and Styrene. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
271. IARC (1999): IARC Monograph Summary for Human Immunodeficiency Viruses: HIV-1 (Group 1); HIV-2 (Group 2B). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
272. IARC (1999): IARC Monograph Summary for Human Papilloma Viruses (HPV): HPV Types 16 and 18 (Group 1); HPV Types 31 and 33 (Group 2A); Some HPV Types Other Than 16, 18, 31 and 33 (Group 2B). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
273. IARC (1999): IARC Monograph Summary for Human T-Cell Lymphotropic Viruses: HTLV-I (Group 1); HTLV-II (Group 3). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
274. IARC (2001): IARC Monograph Summary for Some Internally Deposited Radionuclides. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
275. IARC (2002): IARC Monograph Summary for Tobacco Smoke and Involuntary Smoking. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
276. IARC (2000): IARC Monograph Summary for Ionizing Radiation. Part 1. X- and gamma (y)-Radiation, and Neutrons. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/allmonos.html).
277. IARC (1999): IARC Monograph Summary for Infection with Liver Flukes (Opisthorchis viverrini, Opisthorchis felineus, and Clonorchis sinensis): Opisthorchis viverrini (Group 1); Opisthorchis felineus (Group 3); Clonorchis sinensis (Group 2A). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
278. IARC (1998): IARC Monograph Summary for Hormonal Contraception and Postmenopausal Hormonal Therapy. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
279. IARC (1999): IARC Monograph Summary for Oral Contraceptives, Combined (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
280. IARC (1999): IARC Monograph Summary for Salted Fish: Chinese-Style Salted Fish (Group 1); Other Salted Fish (Group 3). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi^iltound/chem/ilt_chem_frames.html).
281. IARC (1999): IARC Monograph Summary for Infection with Schistomsomes (Schistosoma haematobium, Schistosoma mansoni, and Schistosoma japonicum): Schistosoma haematobium (Group 1); Schistosoma mansoni (Group 3); Schistosoma japonicum (Group 2B). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
282. IARC (1999): IARC Monograph Summary for Silica-rystalline Silica: Inhaled in the Form of Quartz or Cristobalite from Occupational Sources (Group 1); Amorphous Silica (Group 3). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
283. IARC (1999): IARC Monograph Summary for Solar and Ultraviolet Radiation: Solar Radiation (Group 1), Ultraviolet A Radiation (Group 2A), Ultraviolet B Radiation (Group 2A), Ultraviolet C Radiation (Group 2A), Use of Sunlamps and Sunbeds (Group 2A), Exposure to Fluorescent Lighting (Group 3). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
284. IARC (1997): IARC Monograph Summary for Occupational Exposures to Mists and Vapours from Strong Inorganic Acids and Other Industrial Chemicals. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/mono-eval/allmonos.html).
285. IARC (1999): IARC Monograph Summary for Tamoxifen (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi^iltound/chem/ilt_chem_frames.html).
286. IARC (1999): IARC Monograph Summary for Polychlori-nated Dibenzo-para-dioxins: 2,3,7,8-Tetrachlorodibenzo-para-dioxin (Group 1); Polychlorinated Dibenzo-para-dioxins (Other than 2,3,7,8-Tetrachlorodibenzo-para-dioxin): 2,7-DCDD, 1,2,3,6,7,8-/1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8-HpCDD (Group 3), Dibenzo-para-dioxin (Group 3). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
287. IARC (1999): IARC Monograph Summary for Thiotepa (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
288. IARC (1999): IARC Monograph Summary for Wood Dust (Group 1). International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/cgi/iltound/chem/ilt_chem_frames.html).
289. IARC (2004): Overall Evaluations of Carcinogenicity to Humans. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/monoeval/crthall.html).
290. European Union (1983), as cited in Neumann, H.-G. et al. (1997): Proposed changes in the classification of carcinogenic chemicals in the work area. Reg. Toxicol. Pharmacol., 26:288.
291. IARC (1992): Meeting report: working group on mechanisms of carcinogenesis and the evaluation of carcinogenic risks. Cancer Res., 52:2357.
292. IARC (1999): Overall Evaluations of Carcinogenicity to Humans. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://193.51.164.11/monoeval/crthal.html).
293. IARC (2004): Preamble. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland (http://www-cie.iarc.fr/mono-eval/preamble.html).
294. ACGIH (1998): Guide to Occupational Exposure Values: 1998, American Conference of Governmental Industrial Hygienists Cincinnati, OH.
295. Health Canada (1994), as cited in TERA (1999): Cancer Risk Assessment Methods. Toxicology Excellence for Risk Assessment, Cincinnati, OH (http://www.tera.org/iter/methods/cancer.htm).
296. National Toxicology Program (1998), as cited in American Cancer Society (1998): Cancer Facts & Figures, Publ. No. 98-300M-No.5008.98. American Cancer Society, Atlanta, GA.
297. Bickis, M. and Krewski, D. (1985): Statistical design and analysis of the long-term carcinogenicity bioassay. In: Toxicological Risk Assessment, Vol. 1, edited by D. B. Clay-son, D. Krewski, and I. Munro. CRC Press, Boca Raton, FL, p. 125.
298. Borgert, C. J. et al. (2004): Can mode of action predict mixture toxicity for risk assessment? Toxicol. Appl. Pharmacol., 201:85.